NasdaqGM - Nasdaq Real Time Price • USD OmniAb, Inc. (OABI) Follow Compare 3.2150 +0.0050 +(0.16%) As of 11:49:47 AM EST. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations 3 US Penny Stocks With Market Caps Over $300M To Watch The U.S. stock market recently faced a downturn as concerns over China's advancements in artificial intelligence technology weighed heavily on major indices, particularly affecting the tech sector. For investors seeking opportunities beyond large-cap stocks, penny stocks—though an older term—still hold potential for growth and value. These typically smaller or newer companies can offer affordability and growth potential when backed by strong financials, making them worth watching amidst... OmniAb Insider Ups Holding During Year Looking at OmniAb, Inc.'s ( NASDAQ:OABI ) insider transactions over the last year, we can see that insiders were net... Why OmniAb, Inc. (OABI) Is One of the Best Biotech Penny Stocks to Invest in Now? We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where OmniAb, Inc. (NASDAQ:OABI) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower […] US Penny Stocks To Watch In December 2024 As December 2024 unfolds, the U.S. stock market faces a challenging period with significant declines in major indices like the Dow Jones and S&P 500, marking their worst month since April. Amid these fluctuations, investors often turn their attention to penny stocks—companies with lower share prices that can offer intriguing opportunities for growth despite their vintage terminology. By focusing on those penny stocks with strong financials and potential for stability, investors may find... With 55% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns Key Insights Significantly high institutional ownership implies OmniAb's stock price is sensitive to their trading... OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference EMERYVILLE, Calif., December 16, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company’s technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San Diego. Promising US Penny Stocks To Watch In November 2024 As U.S. stock futures rise and major indexes approach record highs, investors are increasingly looking for opportunities in various sectors of the market. Penny stocks, while often seen as a relic from past trading eras, remain relevant due to their potential for growth when supported by strong financials. These smaller or newer companies can offer a unique blend of affordability and growth potential, making them an intriguing option for those seeking hidden value in the market. OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates As you might know, OmniAb, Inc. ( NASDAQ:OABI ) last week released its latest quarterly, and things did not turn out so... OmniAb Inc (OABI) Q3 2024 Earnings Call Highlights: Strong Program Growth Amid Revenue Challenges OmniAb Inc (OABI) showcases robust program expansion and strategic partnerships, despite facing revenue declines and industry pressures. OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates OmniAb, Inc. (OABI) delivered earnings and revenue surprises of -14.29% and 52.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights EMERYVILLE, Calif., November 12, 2024--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner program updates. OmniAb to Participate in Two Investor Conferences in November EMERYVILLE, Calif., October 30, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of November. 3 Promising US Penny Stocks With Market Caps Under $500M As major U.S. indexes experience fluctuations with technology stocks leading the decline and Treasury yields on the rise, investors are exploring alternative opportunities in less conventional areas of the market. Penny stocks, often representing smaller or newer companies, remain a relevant investment area despite their somewhat outdated name. These stocks can offer unique growth potential when backed by strong financials and fundamentals, presenting an underappreciated opportunity for those... OmniAb to Report Third Quarter 2024 Financial Results on November 12 EMERYVILLE, Calif., October 22, 2024--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on Tuesday, November 12, 2024 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth? Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and... OmniAb Inc (OABI) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... OmniAb Inc (OABI) reports increased revenue and new partnerships, while navigating program discontinuations and competitive pressures. OmniAb to Participate in Two Investor Conferences in September EMERYVILLE, Calif., August 26, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of September. OmniAb Second Quarter 2024 Earnings: Beats Expectations OmniAb ( NASDAQ:OABI ) Second Quarter 2024 Results Key Financial Results Revenue: US$7.61m (up 9.6% from 2Q 2023). Net... OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights EMERYVILLE, Calif., August 08, 2024--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and six months ended June 30, 2024, and provided operating and partner program updates. OmniAb to Report Second Quarter 2024 Financial Results on August 8 EMERYVILLE, Calif., July 25, 2024--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Thursday, August 8, 2024 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Performance Overview Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return OABI S&P 500 YTD -9.69% +3.41% 1-Year -46.59% +24.03% 3-Year -67.53% +37.83%